CRISPR

+$2.02 (+1.70%) Today
+$0.28 (+0.23%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRISPR and other ETFs, options, and stocks.

About CRSP

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA.

CEO
Samarth Kulkarni
Employees
410
Headquarters
Zug, Zug
Founded
2014

CRSP Key Statistics

Market Cap
9.17B
Price-Earnings Ratio
23.69
Dividend Yield
—
Average Volume
1.14M
High Today
$125.27
Low Today
$119.42
Open Price
$122.61
Volume
1.43M
52 Week High
$220.20
52 Week Low
$76.71

CRSP News

BenzingaJul 30

Why CRISPR Therapeutics' Stock Is Trading Higher Today

CRISPR Therapeutics AG (NASDAQ: CRSP) is trading higher Friday morning after the company announced second-quarter financial results that showed significant impr

CRSP Earnings

-$1.51
$2.14
$5.79
$9.44
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
$3.52 per share
Actual
$9.44 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure